Načítá se...
Chloroquine nasal drops in asymptomatic & mild COVID-19: An exploratory randomized clinical trial
BACKGROUND & OBJECTIVES: Chloroquine (CQN) administered as nasal drops has the potential to achieve much greater local tissue levels than with oral/systemic administration. This trial was undertaken to study the efficacy and safety profile of topical nasal administration of CQN drops in reducing...
Uloženo v:
| Vydáno v: | Indian J Med Res |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer - Medknow
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8184066/ https://ncbi.nlm.nih.gov/pubmed/33818472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijmr.IJMR_3665_20 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|